STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
LAB on Nasdaq
Shares outstanding
384,731,503
Price per share
$1.28
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
285,864,576
Total reported value
$371,613,646
% of total 13F portfolios
0%
Share change
+5,131,635
Value change
+$7,179,115
Number of holders
155
Price from insider filings
$1.28
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Casdin Capital, LLC 24% +12% $107,459,205 +$14,465,243 93,442,787 +16% Eli Casdin 25 Nov 2025
MAK Capital Fund LP 5.2% $25,564,473 19,967,565 MAK Capital Fund LP 31 Dec 2025

As of 30 Sep 2025, 155 institutional investors reported holding 285,864,576 shares of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB). This represents 74% of the company’s total 384,731,503 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Casdin Capital, LLC 20% 77,558,856 +1.9% 8.4% $100,826,513
VIKING GLOBAL INVESTORS LP 15% 58,651,170 0% 0.2% $76,246,521
BlackRock, Inc. 6.5% 24,920,918 +0.39% 0% $32,397,194
VANGUARD GROUP INC 4.5% 17,245,583 +1.6% 0% $22,419,257
MAK CAPITAL ONE LLC 4.1% 15,931,806 +185% 4.1% $20,711,348
Long Focus Capital Management, LLC 3% 11,362,804 +13% 0.87% $14,771,645
GEODE CAPITAL MANAGEMENT, LLC 1.9% 7,468,917 +0.37% 0% $9,711,117
STATE STREET CORP 1.7% 6,402,649 +1.6% 0% $8,323,444
MORGAN STANLEY 1.7% 6,355,152 +2.1% 0% $8,261,698
Hollow Brook Wealth Management LLC 1.5% 5,775,739 +2.9% 1.8% $7,508,461
Sumitomo Mitsui Trust Group, Inc. 1.4% 5,391,829 -13% 0% $7,009,378
Amova Asset Management Americas, Inc. 1.4% 5,391,829 -12% 0.07% $7,009,378
NEUBERGER BERMAN GROUP LLC 1.2% 4,725,812 +4.7% 0% $6,136,032
Tikvah Management LLC 0.92% 3,551,152 -30% 1.4% $4,616,498
BARCLAYS PLC 0.83% 3,174,634 -4% 0% $4,127,025
ARK Investment Management LLC 0.79% 3,021,728 -4.2% 0.02% $3,928,246
ROYCE & ASSOCIATES LP 0.73% 2,804,719 +6.4% 0.04% $3,646,135
NORTHERN TRUST CORP 0.67% 2,593,910 -2.5% 0% $3,372,083
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.65% 2,504,180 -1.5% 0% $3,255,434
Nan Fung Group Holdings Ltd 0.49% 1,883,179 0% 4.1% $2,448,133
Slate Path Capital LP 0.42% 1,615,000 0% 0.03% $2,099,500
MILLENNIUM MANAGEMENT LLC 0.38% 1,453,575 -38% 0% $1,889,647
Pacific Capital Partners Ltd 0.34% 1,325,000 -3.6% 1.9% $1,722,500
GOLDMAN SACHS GROUP INC 0.34% 1,295,966 -1.8% 0% $1,684,756
Bank of New York Mellon Corp 0.21% 798,138 +2.6% 0% $1,037,580

Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 613,708 $784,889 -$1,033,592 $1.28 8
2025 Q3 285,864,576 $371,613,646 +$7,179,115 $1.30 155
2025 Q2 280,617,967 $336,678,756 -$1,077,649 $1.20 160
2025 Q1 281,593,693 $304,150,404 +$2,261,591 $1.08 146
2024 Q4 278,358,696 $487,066,151 -$5,656,598 $1.75 142
2024 Q3 281,191,207 $542,598,457 +$19,046,404 $1.93 141
2024 Q2 271,250,577 $480,012,531 -$2,577,119 $1.77 142
2024 Q1 265,331,245 $719,039,050 +$591,982,233 $2.71 144
2023 Q4 48,586,557 $107,409,627 +$2,035,800 $2.21 85
2023 Q3 47,429,426 $137,541,583 +$3,894,497 $2.90 72
2023 Q2 46,157,930 $89,085,103 +$111,792 $1.93 65
2023 Q1 46,097,170 $89,907,739 -$81,853 $1.95 68
2022 Q4 46,484,322 $54,406,276 -$819,975 $1.17 64
2022 Q3 38,636,548 $42,509,290 -$7,842,523 $1.10 59
2022 Q2 43,847,181 $70,155,656 -$17,366,200 $1.60 78
2022 Q1 49,928,925 $179,403,697 -$25,702,881 $3.59 103
2021 Q4 56,282,734 $220,394,393 -$14,652,768 $3.92 116
2021 Q3 58,458,125 $385,676,880 +$6,106,049 $6.59 116
2021 Q2 57,580,036 $354,421,486 -$3,050,736 $6.16 111
2021 Q1 59,027,044 $266,772,403 -$44,846,104 $4.52 131
2020 Q4 65,301,638 $391,716,950 -$13,720,267 $6.00 143
2020 Q3 65,965,282 $490,378,526 +$31,961,867 $7.43 131
2020 Q2 62,199,691 $249,441,661 -$3,129,865 $4.01 109
2020 Q1 64,133,221 $162,874,520 -$2,025,145 $2.54 101
2019 Q4 64,001,413 $222,706,158 -$9,721,596 $3.48 97
2019 Q3 63,874,892 $295,826,385 -$69,618,988 $4.63 123
2019 Q2 70,171,968 $864,468,233 +$79,902,351 $12.32 132
2019 Q1 64,290,483 $854,388,750 +$81,402,298 $13.29 131
2018 Q4 49,428,619 $426,070,543 +$92,525,147 $8.62 98
2018 Q3 38,859,260 $291,060,176 +$6,429,245 $7.49 79
2018 Q2 38,051,469 $226,778,750 +$6,133,731 $5.96 83
2018 Q1 37,033,370 $216,300,895 +$1,844,056 $5.84 80
2017 Q4 36,719,372 $217,359,750 +$4,377,610 $5.89 79
2017 Q3 36,202,469 $182,460,122 +$50,176,034 $5.04 77
2017 Q2 26,292,789 $106,212,221 -$4,700,293 $4.04 76
2017 Q1 27,134,410 $154,387,592 +$9,951,922 $5.69 78
2016 Q4 26,899,693 $195,651,510 -$9,634,235 $7.28 80
2016 Q3 27,197,265 $217,785,922 -$2,947,507 $8.01 91
2016 Q2 27,258,899 $246,146,890 -$13,971,192 $9.03 93
2016 Q1 28,544,853 $230,427,557 -$6,987,254 $8.07 95
2015 Q4 28,331,449 $306,249,733 -$18,748,499 $10.81 101
2015 Q3 31,054,676 $251,838,548 -$43,450,033 $8.11 101
2015 Q2 30,992,622 $749,720,524 -$49,296,665 $24.20 105
2015 Q1 30,648,463 $1,288,987,148 +$16,990,892 $42.10 103
2014 Q4 30,375,951 $1,024,527,502 +$65,370,838 $33.73 100
2014 Q3 28,669,722 $702,404,693 +$40,789,532 $24.50 98
2014 Q2 26,798,422 $787,833,600 -$670,493 $29.40 104
2014 Q1 26,208,819 $1,153,738,282 +$79,524,977 $44.07 106